Overview

Tech Summary

Promoter Holding

Posts

MARKSANS

6012345678920123456789.8012345678900123456789
-1.15 (-1.80%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 63.95
1D
5D
1M
3M
1Y
5Y
Today's low
62.4
Today's high
64.75
52 week low
38.6
52 week high
69.6
Volume
2129535
About
Tech Summary
DMA(12)
₹57.49
DMA(50)
₹50.97
DMA(100)
₹50.89
DMA(200)
₹49.9
Fund Summary
Market Cap
₹2570.4 Cr.
Enterprise Value
₹2376.85 Cr.
No. of Shares
40.93
P/E
13.76
RoE
31.33
Debt/Equity
0.02
Valuations
PE Chart
1618202224
PB Chart
1.41.61.82.02.2
Promoter Holdings
Public : 47.67%
FII : 3.46%
DII : 0.62%
Promoter : 48.25%
Others : 0%
Charts
Debt/Equity
0.050.100.150.200.25
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE vs ROCE
10203040
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE
ROCE
Revenue vs Profitability (1000Cr.)
0.20.40.60.81.01.21.4
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Revenue
Profit
Margins(%)
510152025
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Net Margin
Gross Margin
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Price Target Potential
Brokerage
Arihant Capital Markets
Target
86
Potential
63.19%
Stock Sentiments
100% Bullish
0% Bearish
10 live trades of Rs. 740,292
V
vikkysankar
 
Reputation: 0 • 
Jan 25 5:34 PM
MARKSANS
1000 Qty (B) New Trade
L
lifaaz
 
Reputation: 0 • 
Jan 25 5:27 PM
MARKSANS
10 Qty (B) Expired before entry
Posts by FrontPage Users
NewsBot-display-image
Reputation: 29,719  •  Jan 14 3:16 PM
These 28 smallcaps steal limelight, give double-digit weekly returns
These 28 smallcaps steal limelight, give double-digit weekly returns
Similarly in the US, consumer price inflation in December had fallen for the first time since May 2020. Buoyed by these encouraging data points, indices on Friday ended in the green, which helped them clock marginal gains for the week.
The Economic Times
Like
Comment
Share
Add a comment
P
Reputation: 576  •  Jan 13 12:10 PM

hey guys have you hear about MARKSANS PHARMA amazing fundamentally strong stock and recently this stock hit 52 week high best time to invest i buy near 50 i am new on this platform otherwise i definetly share with you earlier usually i find smallcap stocks to invest and this is o......read more
2 Likes
Comment
Share
Add a comment
Financialwavetrader-display-image
Reputation: 2,304  •  Dec 7, 2022 12:34 AM

#MARKSANS Keep On radar CMP 63.80

Price moving up with volume since 4-5 weeks

Positive RSI Daily weekly & Monthly
Chartbusters - chart - 18018591
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Nov 29, 2022 6:26 PM
Buy Marksans Pharma, target price Rs 66.6:  HDFC Securities
Buy Marksans Pharma, target price Rs 66.6: HDFC Securities
Marksans Pharma, incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 2423.92 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Oct 13, 2022 12:31 AM
Marksans  stock zooms 12% after news of Tevapharm facility buy
Marksans stock zooms 12% after news of Tevapharm facility buy
Despite the rally, its shares have dropped 10 per cent in the last one month and the stock has tumbled 25 per cent so far in 2022
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Oct 12, 2022 7:21 PM
Marksans  stock zooms 12% after news of Tevapharm facility buy
Marksans stock zooms 12% after news of Tevapharm facility buy
Despite the rally, its shares have dropped 10 per cent in the last one month and the stock has tumbled 25 per cent so far in 2022
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Oct 12, 2022 5:48 PM
Capacity addition from Tevapharm sends Marksans Pharma up 6%
Capacity addition from Tevapharm sends Marksans Pharma up 6%
Through the acquisition, the company plans to double its existing Indian capacity from 8 billion units per annum currently
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Aug 23, 2022 2:16 PM
Corporate Radar: JK Paper, Sun TV to turn ex-dividend; AGMs, and more
Corporate Radar: JK Paper, Sun TV to turn ex-dividend; AGMs, and more
Shyam Century Ferrous (Re 0.3 per share) and Sun TV Network (Rs 5 per share) had announced their interim dividends. Shares of 7NR Retail will turn ex-rights today. The company had announced a rights issue of 1 share for every 1 share held, offered at Rs 1.4 apiece. Fine Organic Industries and Salem Erode Investments will have their annual general meetings (AGM) today.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jul 8, 2022 1:16 PM
Corporate Radar: Titan to turn ex-dividend; TCS Q1 results; Havells India AGM & more
Corporate Radar: Titan to turn ex-dividend; TCS Q1 results; Havells India AGM & more
Tata Consultancy Services, MMTC, Kohinoor Foods, Shrenik, Brahmaputra Infrastructure, Morarka Finance and Spectrum Foods are among companies that will announce their quarterly earnings today.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jul 5, 2022 4:16 PM
Marksans Pharma rallies 12% after board sets date to consider buyback
Marksans Pharma rallies 12% after board sets date to consider buyback
Marksans Pharmas filing to the exchanges about the buyback proposal said a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 8th July 2022 to consider the proposal for buyback of fully paid-up equity shares of the company.
The Economic Times
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  May 29, 2022 12:30 AM

#MARKSANS will declare results on May 30, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Smart Money-display-image
Reputation: 8,423  •  May 15, 2022 4:24 AM
MARKSANS PHARMA LTD Trend Analysis for NSE:MARKSANS by Swastik86
MARKSANS PHARMA LTD Trend Analysis for NSE:MARKSANS by Swastik86
An undervalued debt free small cap pharma with strong fundamentals available at a PE below 8. A potential Cup with Handle pattern is forming. Expecting price to reach green support zone highlighted, Golden FIB and Pitchfork edge is adding more confluence to that level. Good to accumulate around 35-40 levels for the following targets: Short term swing target @ 67 (78.5% ROI with 3.93 R:R) Medium term positional target @ 105 (180% ROI with 9 R:R) Long term positional target @ 180 (380% ROI …
TradingView

An undervalued debt free small cap pharma with strong fundamentals available at a PE below 8.
A potential Cup with Handle pattern is forming.
Expecting price to reach the green support zone highlighted, Golden FIB and Pitchfork edge is adding more confluence to that level. Now pr......read more
Chartbusters - chart - 9270588
3 Likes
3 Comments
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Apr 26, 2022 12:26 AM
Marksans Pharma acquires Dubai-based Access Healthcare to expand in MENA region
Marksans Pharma acquires Dubai-based Access Healthcare to expand in MENA region
For the year ended December 2021, Access Healthcare had revenues of Rs 25 crore and a profit after tax of Rs 9.4 crore. The company has no debt on its books.
The Economic Times
Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,809  •  Feb 16, 2022 8:30 PM

Arihant Capital Markets target on MARKSANS
Date: 16-Feb-22 Broker: Arihant Capital Markets Price @ Call: 50 Target: 86 Potential: 72% Recommendation: BUY
2 Likes
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  Feb 10, 2022 12:30 AM

#MARKSANS will declare results on Feb 11, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Dec 10, 2021 6:32 PM
link
Marksans Pharma jumps 8%; arm gets UK MHRA nod for Loperamide capsule
According to reports, Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility in Goa.
The Economic Times
Like
Comment
Share
Add a comment
Harry-display-image
Reputation: 1,825  •  Nov 11, 2021 1:01 AM

*Marksans Pharma Ltd.* | *CMP* Rs. 66 | *M Cap* Rs. 2712 Cr | *52 W H/L* 98/48
(Nirmal Bang Retail Research)
*Result is declining*
Revenue from Operations came at Rs. 361.2 Cr (3.5% QoQ, 1.3% YoY) vs QoQ Rs. 349 Cr, YoY Rs. 356.5 Cr
EBIDTA came at Rs. 60.1 Cr (-22.3% QoQ, -27.7% ......read more
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  Nov 9, 2021 12:30 AM

#MARKSANS will declare results on Nov 10, 2021
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  Nov 8, 2021 12:30 AM

#MARKSANS will declare results on Nov 9, 2021
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
The Chartseeker-display-image
Reputation: 4,487  •  Oct 1, 2021 5:31 AM

Buy #MARKSANS @ 69
TGT 75
SL 67
NOTE : I AM NOT SEBI REGISTERED. ITS ONLY MY PERSONAL VIEW AND ONLY FOR EDUCATION PURPOSE NOT FOR TRADE.
2 Likes
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,809  •  Aug 20, 2021 6:30 AM

Arihant Capital Markets target on MARKSANS
Date: 01-Jun-21 Broker: Arihant Capital Markets Price @ Call: 74 Target: 86 Potential: 16.22% Recommendation: ACCUMULATE
1 Like
Comment
Share
Add a comment
ReportBot-display-image
Reputation: 39,809  •  Aug 20, 2021 6:30 AM

Arihant Capital Markets target on MARKSANS
Date: 01-Jun-21 Broker: Arihant Capital Markets Price @ Call: 74 Target: 86 Potential: 16.22% Recommendation: ACCUMULATE
Like
Comment
Share
Add a comment
KrisDom Investor-display-image
Reputation: 29,811  •  Aug 11, 2021 5:55 PM

MARKSANS PHARMA: Q1 CONS NET PROFIT 626M RUPEES VS 493M (YOY); 795M (QOQ)

MARKSANS PHARMA: Q1 REVENUE 3.49B RUPEES VS 3.3B (YOY); 3.3B (QOQ)

MARKSANS PHARMA:Q1 EBITDA RUPEES 774M VS 700M (YOY); 953M (QOQ) || Q1 EBITDA MARGIN 22.2% VS 21.14% (YOY); 28.88% (QOQ)
#MARKSANS #Inves......read more
7 Likes
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 20,269  •  Aug 10, 2021 12:30 AM

#MARKSANS will declare results on Aug 11, 2021
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
U
Reputation: 16  •  Jul 20, 2021 2:13 AM

MARKSANS PHARMA

CMP : 88.45
Support at 84.8

Good contraction going on, expecting a breakout

#MARKSANS #NSE #BSE #TRADER #BREAKOUTS
MARKSANS - 3938429
Like
Comment
Share
Add a comment
Gyanee-display-image
Reputation: 8,830  •  Jul 18, 2021 2:58 PM

An analyst specialising in long-term picks recommends TVS Electronics, Jubilant Industries (JIVANJOR), Marksans Pharma, Hemisphere Properties and Shemaroo Entertainment for multi-bagger gains.

Like
Comment
Share
Add a comment
Banknifty Option-display-image
Reputation: 2,469  •  Jul 17, 2021 5:03 PM
Like
Comment
Share
Add a comment
Shivansh-display-image
Reputation: 6,012  •  Jun 27, 2021 9:43 PM
Firstinvestment in HDFCBANK
Dividends with Purpose and Ex Dates #HDFCBANK ...
3 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jun 14, 2021 11:11 PM
Biggest gainers & losers of the day: Godawari Power gains 20%, BHEL drops 12%
Biggest gainers & losers of the day: Godawari Power gains 20%, BHEL drops 12%
Adani Group stocks tumbled up to 25 per cent before recovering. BHEL tanked 12 per cent, but Godawari Power and e-Clerx Services continued the winning streak.
The Economic Times
Like
Comment
Share
Add a comment
Shivansh-display-image
Reputation: 6,012  •  Jun 14, 2021 3:31 PM
3 Likes
Comment
Share
Add a comment
KrisDom Investor-display-image
Reputation: 29,811  •  Jun 14, 2021 11:27 AM

Marksans Pharma has issued convertible warrants to its promoters and other QIP investors convertible into shares at Rs. 74 per share. Retail investors may take a cue and add.

5 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Jun 11, 2021 4:31 PM
Marksans Pharma hits upper cicuit as company considers preferential allotment
Marksans Pharma hits upper cicuit as company considers preferential allotment
Shares of Marksans Pharma rallied 20 per cent, its upper circuit limit, to Rs 83.70 on Friday. However the counter was trading at Rs 81.75 at 10.35 am. BSE Sensex was up by 297.24 points or 0.57 per cent at 52,597.71 at the same time. The stock settled at Rs 69.75 on Thursday.
The Economic Times
Like
Comment
Share
Add a comment
Billion Club-display-image
Reputation: 14,912  •  Jun 11, 2021 4:13 PM
Like
Comment
Share
Add a comment
Bull Flair-display-image
Reputation: 1,854  •  Jun 11, 2021 2:17 PM
Like
Comment
Share
Add a comment
Stock Info Official-display-image
Reputation: 3,414  •  Jun 1, 2021 1:35 AM

Marksans Pharma Standalone March 2021 Net Sales at Rs 137.58 crore, up 21.07% Y-o-Y
Net Sales at Rs 137.58 crore in March 2021 up 21.07% from Rs. 113.64 crore in March 2020.

Quarterly Net Profit at Rs. 23.69 crore in March 2021 up 219.63% from Rs. 7.41 crore in March ......read more
Like
Comment
Share
Add a comment
Sridhar Balakrishnan-display-image
Reputation: 193,930  •  May 13, 2021 6:15 PM
1 Like
Comment
Share
Add a comment
Sridhar Balakrishnan-display-image
Reputation: 193,930  •  Mar 21, 2021 11:04 PM

#MarksansPharma @53
A strong formulation player with manufacturing facilities in UK, USA, and India.
The product portfolio covers pain, diabetes, cardiovascular, cough-cold, GI and CNS, etc.
A significant increase in margins along with revenue (3......read more
10 Likes
Comment
Share
Add a comment
Indyan-display-image
Reputation: 5,428  •  Mar 5, 2021 1:46 AM

MARKSANS - 2337505
#MARKSANS This one came in a scanner Potential Multibagger.
Aap Name: Screener
1 Like
Comment
Share
Add a comment
NinjaMoku-display-image
Reputation: 2,158  •  Dec 7, 2020 2:14 AM
Like
Comment
Share
Add a comment
ChartArt-display-image
Reputation: 412  •  Dec 3, 2020 5:29 PM

MARKSANS - chart - 1722919
Last chart of the Episode 3
Chart 5
#ChartArt #EducationalPurposes
#BullishView
Manage your risk
Like
Comment
Share
Add a comment
Alpha Signals-display-image
Reputation: 29,890  •  Nov 24, 2020 4:27 PM
ravikanthchopperla in MARKSANS
New Momentum Trade Idea Marksans Pharma Ltd ...

Removal Alert - Due to Technical Weakness in this Counter Advising to Exit
Entry at INR 61/- Exit At INR 59.70/- Loss of INR 1.30/- Per unit

Like
Comment
Share
Add a comment
Alpha Signals-display-image
Reputation: 29,890  •  Nov 22, 2020 10:43 PM

MARKSANS - chart - 1671249
New Momentum Trade Idea
Marksans Pharma Ltd
LTP INR 61/-
Profit Target Goal INR 68/-
Reward To Risk Ratio 1:40
Our aim is to take ~13%
Stop Loss INR 56/-
MACD 1.5 Above Signal
RSI 75 Over Bought
PE Trailing 12M 14.5 Below Industry Median
Note :- High Financial Strength, M......read more
5 Likes
Comment
Share
Add a comment
Sridhar Balakrishnan-display-image
Reputation: 193,930  •  Nov 22, 2020 5:44 PM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Nov 15, 2020 4:18 PM
Indian drug firms recall various products in US market
Indian drug firms recall various products in US market
While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid.
Moneycontrol
Like
Comment
Share
Add a comment
Sridhar Balakrishnan-display-image
Reputation: 193,930  •  Nov 8, 2020 12:46 PM
4 Likes
Comment
Share
Add a comment
Sridhar Balakrishnan-display-image
Reputation: 193,930  •  Nov 8, 2020 12:27 PM

*Marksans Pharma Ltd.* | *CMP* Rs. 54 | *M Cap* Rs. 2210 Cr | *52 W H/L* 57/10
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 356.5 Cr (7.6% QoQ, 39% YoY) vs QoQ Rs. 331.2 Cr, YoY Rs. 256.4 Cr
EBIDTA came at Rs. 83.2 Cr (18.8% Q......read more
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Oct 14, 2020 10:08 PM
Ashish Kacholia buys nearly 51 lakh shares of Marksans Pharma in September quarter
Ashish Kacholia buys nearly 51 lakh shares of Marksans Pharma in September quarter
In a regulatory filing on October 14, Marksans Pharma said Kacholia bought 50,99,945 shares during the quarter.
Moneycontrol
Like
Comment
Share
Add a comment
Great Eagle Capital -display-image
Reputation: 12,603  •  Aug 28, 2020 4:08 AM

MARKSANS - chart - 1225094
#MARKSANS MEDIUM TERM BUY MODE TGT 66/93 SL 46 ( WEEKLY CLBS)
Like
Comment
Share
Add a comment
Tta-display-image
tta 
Reputation: 13,292  •  Aug 27, 2020 9:05 PM

Marksan Pharma
view: Positive for long term
Marksans Pharma is engaged in Business of Formulation of pharmaceutical products. It has built a steady franchise in the regulated market space of the UK and US (over 80% revenues), with a front-end presence through subsidiaries. Operat......read more
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,719  •  Aug 20, 2020 3:51 PM
Share market update: 67 stocks hit 52-week highs on NSE
Share market update: 67 stocks hit 52-week highs on NSE
The BSE Sensex was trading 290.12 points down at 38324.67.
The Economic Times
Like
Comment
Share
Add a comment
Load More Posts